5Ward R L, McNeal M M, Steele A D. Why does the world need another rotavirus vaceine[J]? Ther Clin Risk Manag, 2008,4 ( 1 ) : 49-63.
6Ward R L, Bernstein D I. Rotarix: a rotavirus vaccine for the world[J]. Clin Infect Dis,2009,48(2):222-228.
7Ruiz-Palacios G M, Perez-Schael I, Velazquez F R, et al. Safety and efficacy of an attennated vaccine against severe rotavirus gastroenteritis[J]. N Engl J Med,2006, 354(1) :11-22.
8Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study[J]. Lancet,2007, 370:1757-1763.
9Alexandre C, Linhares M D , et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind,placebo-controlled phase III study[J]. Lancet, 2008,371 : 1181-1189.
10Vesikari T ,Matson Do ,Dennehy P , et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassorrant rotavirus vaccine1 [J]. N Engl J Med, 2006,354 (1):23-33.
5DENNEHY P H. Rotavlrus vaccines - an update [ J ]. Vaccine, 2007,25(16) :3137 -3141.
6PARASHAR U D. Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children[ J]. Emerg Infect Dis. 2003,9:565 - 572.
8Samia Rourou,Arno Ark,Samy Majoul,Khaled Trabelsi,Tiny Velden,Héla Kallel.A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor[J],2009.
9Schuller E,Jilma B,Voicu V,et al.Long-term immunogenicityof the new Vero cell-derived,inactivated Japanese encephalitis vi-rus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 studyVaccine,2008.
10Toriniwa H,Komiya T.Japanese encephalitis virus production inVero cells with serum-free medium using a novel oscillating biore-actorBiologicals,2007.
